Discomfort with uncertainty: Is testing for Brugada syndrome in the neonatal period warranted?

Michelle N. Vazquez, Gabrielle Gold-von Simson

Research output: Contribution to journalArticle

Abstract

Brugada syndrome (BrS) is rare genetic disorder, which manifests as syncope or sudden death caused by polymorphic ventricular tachycardia. Diagnosis is based on symptoms and characteristic electrocardiography findings. Identification of mutations in SCN5A support the diagnosis, but the yield is low. According to experts, BrS patients with a history of cardiac arrest should have insertion of an automatic implantable cardiac defibrillator and asymptomatic patients can be managed conservatively. Treatment challenges occur in patients with "intermediate" clinical characteristics and in populations where there is paucity of data such as with neonates and children. We discuss the case of a woman with BrS who is faced with decision challenges in the postpartum period. Should her newborn have testing? When? Will deferment of testing impose an unreasonable uncertainty due to delay of diagnosis? Or conversely, will premature workup impose an unnecessary intervention?.

Original languageEnglish (US)
Pages (from-to)97-101
Number of pages5
JournalJournal of Pediatric Genetics
Volume2
Issue number2
DOIs
StatePublished - Jan 1 2013
Externally publishedYes

Fingerprint

Brugada Syndrome
Uncertainty
Newborn Infant
Inborn Genetic Diseases
Implantable Defibrillators
Syncope
Population Characteristics
Ventricular Tachycardia
Sudden Death
Heart Arrest
Postpartum Period
Electrocardiography
Mutation
Therapeutics

Keywords

  • Brugada syndrome
  • Genetic testing
  • Neonatal

ASJC Scopus subject areas

  • Pediatrics, Perinatology, and Child Health
  • Genetics(clinical)

Cite this

Discomfort with uncertainty : Is testing for Brugada syndrome in the neonatal period warranted? / Vazquez, Michelle N.; Gold-von Simson, Gabrielle.

In: Journal of Pediatric Genetics, Vol. 2, No. 2, 01.01.2013, p. 97-101.

Research output: Contribution to journalArticle

Vazquez, Michelle N. ; Gold-von Simson, Gabrielle. / Discomfort with uncertainty : Is testing for Brugada syndrome in the neonatal period warranted?. In: Journal of Pediatric Genetics. 2013 ; Vol. 2, No. 2. pp. 97-101.
@article{a8da903b1fad45c6bf335e96cde74195,
title = "Discomfort with uncertainty: Is testing for Brugada syndrome in the neonatal period warranted?",
abstract = "Brugada syndrome (BrS) is rare genetic disorder, which manifests as syncope or sudden death caused by polymorphic ventricular tachycardia. Diagnosis is based on symptoms and characteristic electrocardiography findings. Identification of mutations in SCN5A support the diagnosis, but the yield is low. According to experts, BrS patients with a history of cardiac arrest should have insertion of an automatic implantable cardiac defibrillator and asymptomatic patients can be managed conservatively. Treatment challenges occur in patients with {"}intermediate{"} clinical characteristics and in populations where there is paucity of data such as with neonates and children. We discuss the case of a woman with BrS who is faced with decision challenges in the postpartum period. Should her newborn have testing? When? Will deferment of testing impose an unreasonable uncertainty due to delay of diagnosis? Or conversely, will premature workup impose an unnecessary intervention?.",
keywords = "Brugada syndrome, Genetic testing, Neonatal",
author = "Vazquez, {Michelle N.} and {Gold-von Simson}, Gabrielle",
year = "2013",
month = "1",
day = "1",
doi = "10.3233/PGE-13054",
language = "English (US)",
volume = "2",
pages = "97--101",
journal = "Journal of Pediatric Genetics",
issn = "2146-4596",
publisher = "Georg Thieme Verlag",
number = "2",

}

TY - JOUR

T1 - Discomfort with uncertainty

T2 - Is testing for Brugada syndrome in the neonatal period warranted?

AU - Vazquez, Michelle N.

AU - Gold-von Simson, Gabrielle

PY - 2013/1/1

Y1 - 2013/1/1

N2 - Brugada syndrome (BrS) is rare genetic disorder, which manifests as syncope or sudden death caused by polymorphic ventricular tachycardia. Diagnosis is based on symptoms and characteristic electrocardiography findings. Identification of mutations in SCN5A support the diagnosis, but the yield is low. According to experts, BrS patients with a history of cardiac arrest should have insertion of an automatic implantable cardiac defibrillator and asymptomatic patients can be managed conservatively. Treatment challenges occur in patients with "intermediate" clinical characteristics and in populations where there is paucity of data such as with neonates and children. We discuss the case of a woman with BrS who is faced with decision challenges in the postpartum period. Should her newborn have testing? When? Will deferment of testing impose an unreasonable uncertainty due to delay of diagnosis? Or conversely, will premature workup impose an unnecessary intervention?.

AB - Brugada syndrome (BrS) is rare genetic disorder, which manifests as syncope or sudden death caused by polymorphic ventricular tachycardia. Diagnosis is based on symptoms and characteristic electrocardiography findings. Identification of mutations in SCN5A support the diagnosis, but the yield is low. According to experts, BrS patients with a history of cardiac arrest should have insertion of an automatic implantable cardiac defibrillator and asymptomatic patients can be managed conservatively. Treatment challenges occur in patients with "intermediate" clinical characteristics and in populations where there is paucity of data such as with neonates and children. We discuss the case of a woman with BrS who is faced with decision challenges in the postpartum period. Should her newborn have testing? When? Will deferment of testing impose an unreasonable uncertainty due to delay of diagnosis? Or conversely, will premature workup impose an unnecessary intervention?.

KW - Brugada syndrome

KW - Genetic testing

KW - Neonatal

UR - http://www.scopus.com/inward/record.url?scp=85013567556&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85013567556&partnerID=8YFLogxK

U2 - 10.3233/PGE-13054

DO - 10.3233/PGE-13054

M3 - Article

AN - SCOPUS:85013567556

VL - 2

SP - 97

EP - 101

JO - Journal of Pediatric Genetics

JF - Journal of Pediatric Genetics

SN - 2146-4596

IS - 2

ER -